Deferred Tax Assets, Valuation Allowance of INTEGRATED BIOPHARMA INC from 30 Jun 2011 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
INTEGRATED BIOPHARMA INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2011 to 30 Jun 2025.
  • INTEGRATED BIOPHARMA INC Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Jun 2025 was $1,776,000, a 40% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

INTEGRATED BIOPHARMA INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,776,000 +$505,000 +40% 30 Jun 2025 10-K 23 Sep 2025 2025 FY
Q2 2024 $1,271,000 -$164,000 -11% 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q2 2023 $1,435,000 +$294,000 +26% 30 Jun 2023 10-K 20 Sep 2024 2024 FY
Q2 2022 $1,141,000 -$1,932,000 -63% 30 Jun 2022 10-K 15 Sep 2023 2023 FY
Q2 2021 $3,073,000 -$2,575,000 -46% 30 Jun 2021 10-K 13 Sep 2022 2022 FY
Q2 2020 $5,648,000 -$1,898,000 -25% 30 Jun 2020 10-K 02 Sep 2021 2021 FY
Q2 2019 $7,546,000 -$591,000 -7.3% 30 Jun 2019 10-K 23 Sep 2020 2020 FY
Q2 2018 $8,137,000 -$5,257,000 -39% 30 Jun 2018 10-K 29 Aug 2019 2019 FY
Q2 2017 $13,394,000 -$1,320,000 -9% 30 Jun 2017 10-K 12 Sep 2018 2018 FY
Q2 2016 $14,714,000 -$423,000 -2.8% 30 Jun 2016 10-K 01 Sep 2017 2017 FY
Q2 2015 $15,137,000 -$925,000 -5.8% 30 Jun 2015 10-K 02 Sep 2016 2016 FY
Q2 2014 $16,062,000 -$1,573,000 -8.9% 30 Jun 2014 10-K 04 Sep 2015 2015 FY
Q2 2013 $17,635,000 -$413,000 -2.3% 30 Jun 2013 10-K 08 Sep 2014 2014 FY
Q2 2012 $18,048,000 +$1,185,000 +7% 30 Jun 2012 10-K 30 Sep 2013 2013 FY
Q2 2011 $16,863,000 30 Jun 2011 10-K 15 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.